Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rachel B Jones

Showing results (41-50 of 59) with videos related to

Pageof 6
Sort By:
Arthritis & Rheumatology (Hoboken, N.J.)|May 19, 2019
Rituximab as Maintenance Treatment for Systemic Lupus Erythematosus: A Multicenter Observational Study of 147 PatientsMatthias A Cassia, Federico Alberici, Rachel B Jones, et al.
Annals of the Rheumatic Diseases|March 6, 2015
Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis: 2-year results of a randomised trialRachel B Jones, Shunsuke Furuta, Jan Willem Cohen Tervaert, et al.
Trials|March 11, 2023
A randomised study of rituximab and belimumab sequential therapy in PR3 ANCA-associated vasculitis (COMBIVAS): design of the study protocolMark E McClure, Seerapani Gopaluni, James Wason, et al.
The New England Journal of Medicine|July 22, 2010
Rituximab versus cyclophosphamide in ANCA-associated renal vasculitisRachel B Jones, Jan Willem Cohen Tervaert, Thomas Hauser, et al.
BMC Nephrology|June 1, 2022
SARS-COV-2 vaccine responses in renal patient populationsRona M Smith, Daniel J Cooper, Rainer Doffinger, et al.
Rheumatology (Oxford, England)|September 22, 2018
A novel glucocorticoid-free maintenance regimen for anti-neutrophil cytoplasm antibody-associated vasculitisRuth J Pepper, Stephen P McAdoo, Sarah M Moran, et al.
Lancet (London, England)|January 23, 2022
Omicron neutralising antibodies after COVID-19 vaccination in haemodialysis patientsEdward J Carr, Mary Wu, Ruth Harvey, et al.
Rheumatology (Oxford, England)|January 29, 2019
A novel glucocorticoid-free maintenance regimen for anti-neutrophil cytoplasm antibody-associated vasculitisRuth J Pepper, Stephen P McAdoo, Sarah M Moran, et al.
BMC Nephrology|March 28, 2026
The UK Eastern Network for Kidney Inflammatory Disease (ENKID) MDT at 24 months: advancing access to high-cost drugs, clinical trials, and complex case management in renal autoimmune diseasesLucy Francis, Olivia Kanka, Ondrej Suchanek, et al.
Rheumatology (Oxford, England)|May 25, 2026
Incorporating frailty and disease severity into treatment decisions for older patients with ANCA-associated vasculitisMark E McClure, Ayonija Sundararajan, Karl Emil Nelveg-Kristensen, et al.
Pageof 6

Showing results (41-50 of 59) with videos related to

Sort By:
Pageof 6
Arthritis & Rheumatology (Hoboken, N.J.)|May 19, 2019
Rituximab as Maintenance Treatment for Systemic Lupus Erythematosus: A Multicenter Observational Study of 147 PatientsMatthias A Cassia, Federico Alberici, Rachel B Jones, et al.
Annals of the Rheumatic Diseases|March 6, 2015
Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis: 2-year results of a randomised trialRachel B Jones, Shunsuke Furuta, Jan Willem Cohen Tervaert, et al.
Trials|March 11, 2023
A randomised study of rituximab and belimumab sequential therapy in PR3 ANCA-associated vasculitis (COMBIVAS): design of the study protocolMark E McClure, Seerapani Gopaluni, James Wason, et al.
The New England Journal of Medicine|July 22, 2010
Rituximab versus cyclophosphamide in ANCA-associated renal vasculitisRachel B Jones, Jan Willem Cohen Tervaert, Thomas Hauser, et al.
BMC Nephrology|June 1, 2022
SARS-COV-2 vaccine responses in renal patient populationsRona M Smith, Daniel J Cooper, Rainer Doffinger, et al.
Rheumatology (Oxford, England)|September 22, 2018
A novel glucocorticoid-free maintenance regimen for anti-neutrophil cytoplasm antibody-associated vasculitisRuth J Pepper, Stephen P McAdoo, Sarah M Moran, et al.
Lancet (London, England)|January 23, 2022
Omicron neutralising antibodies after COVID-19 vaccination in haemodialysis patientsEdward J Carr, Mary Wu, Ruth Harvey, et al.
Rheumatology (Oxford, England)|January 29, 2019
A novel glucocorticoid-free maintenance regimen for anti-neutrophil cytoplasm antibody-associated vasculitisRuth J Pepper, Stephen P McAdoo, Sarah M Moran, et al.
BMC Nephrology|March 28, 2026
The UK Eastern Network for Kidney Inflammatory Disease (ENKID) MDT at 24 months: advancing access to high-cost drugs, clinical trials, and complex case management in renal autoimmune diseasesLucy Francis, Olivia Kanka, Ondrej Suchanek, et al.
Rheumatology (Oxford, England)|May 25, 2026
Incorporating frailty and disease severity into treatment decisions for older patients with ANCA-associated vasculitisMark E McClure, Ayonija Sundararajan, Karl Emil Nelveg-Kristensen, et al.
Pageof 6